Adagene Inc.

ADAG

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001818838

SEC filings (opens in a new tab)

In the last 90 days, Adagene Inc. insiders filed 4 open-market purchases and 0 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $81.0M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Adagene Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023 All holders in Q1 2023

13F holders of ADAG: Q1 2023 compared with Q2 2023
Measure	Q1 2023	Q2 2023	Change
Holders	11	10	−1
Shares	4.19M	4.11M	−74.8K (−1.8%)
Value	$6.02M	$6.02M	−$7.17K (−0.1%)

New holders (1)

Institutions that held Adagene Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to ADAG in Q2 2023
Institution	Shares	Value	% of portfolio
Rhumbline Advisers	2,215	$3.15K	0.00%

Sold out (2)

Institutions that held Adagene Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of ADAG in Q2 2023
Institution	Shares, Q1 2023	Value, Q1 2023
Cannell Capital LLC	28,998	$42.0K
Citadel Advisors LLC	12,805	$18.1K